Clinical Trial Update: Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay

View source ↗

Summary

A completed validation study evaluating the ImmuKnow assay as a diagnostic tool to assess immunosuppression in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ImmuKnow Assay

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Renal Transplant Recipients | Status: COMPLETED